UPDATE — DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease
MINNEAPOLIS, Jan. 03, 2019 (GLOBE NEWSWIRE) — DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX-V:DMA) announced today that the U.S. Food and […]